EyeControl is a wearable platform that adapts across the ICU journey to support communication, reorientation, and cognitive engagement. These are key risk factors for ICU delirium, a common complication that drives longer stays, poor recovery, and over $150 billion in annual healthcare costs. EyeControl delivers evidence-based, nonpharmacological interventions that address this critical gap, supporting patients, families, and care teams in delivering safer, more connected ICU care.